Daily Stock Market Report (Thur 7th August 2025) - RBN, EMR, SDG, MER, EPWN, RCP, VANQ, MGAM
Good morning and welcome to Thursday's report!
All done for today, thank you.
Spreadsheet accompanying this report: link.
Companies Reporting
| Name (Mkt Cap) | RNS | Summary | Our view (Author) |
|---|---|---|---|
| CRH (LON:CRH) (£49.1bn) | 25Q2 Results | Revenue +6% to $10.2bn, Net Income +2% to $1.3bn, Adj EBITDA +9% to $2.5bn. “nderlying demand in our key end-use markets remains positive and we are pleased to raise our guidance for 2025.” FY25 guidance: Net income of $3.8bn-$3.9bn; Adjusted EBITDA of $7.5bn-$7.7bn. | |
Intercontinental Hotels (LON:IHG) (£13.4bn) | Underlying rev +5%, op profit +13% ($604m). On track to meet consensus profit expectations. | ||
WPP (LON:WPP) (£4.3bn) | LFL revenue & op profit margin outlook unchanged. FCF guidance £1.1-1.2bn (prev: £1.4bn). | BLACK | |
Hikma Pharmaceuticals (LON:HIK) (£4.2bn) | H1 core op profit -7% due to change in product mix. Reiterates full year guidance. | ||
Spectris (LON:SXS) (£4.1bn) | Orders -2% LFL, sales +1% LfL. Full year adjusted op profit to be in line with management exps. | PINK (under offer) | |
Harbour Energy (LON:HBR) (£2.94bn) | Production guidance 460-475 kboepd. Upgrades free cash flow outlook to $1.0bn (from $0.9bn). | ||
RIT Capital Partners (LON:RCP) (£2.7bn) | NAV total return 3.4%. Strongest contribution from Private Investments with 9% return. | GREEN (Graham) [no section below] We don’t normally give this any coverage but I’ve been increasingly interested in investment trusts lately, and what they can do for a portfolio, and I know that many readers like to follow them, too. RIT Capital Partners uses bottom-up investment selection in three categories: quoted equities, private investments, and “uncorrelated strategies” (this bucket includes absolute return, credit, bonds and real assets). The idea is to create a balanced portfolio with more consistent returns than you would get from investing 100% in quoted equities. I think the annualised return over the last 10 years is about 7% (the total return is 102.7% over that timeframe). Volatility around the Covid era was still quite high with a drawdown of about 35%, so it would be wrong to think that returns are perfectly smooth. But for a less dramatic approach than pure equities, I think this trust could have some merit. Today’s results show all three of its pillars generating positive results, and modest gearing of 5.8%. I’m GREEN on it due to the large share price discount available: the share price is £19.42, versus NAV of £26.80, and a buyback is underway. | |
Deliveroo (LON:ROO) (£2.7bn) | Revenue +9%. Loss for the period of £19m due to costs associated with DoorDash acquisition. | PINK (under offer) | |
Just (LON:JUST) (£2.18bn) | Underlying operating profit £192m (H1 2024: £249m). Strong sales outlook for H2. | PINK (under offer) | |
Serco (LON:SRP) (£2.1bn) | Rev +5% at constant current, organically +3%. Revenue and profit guidance unchanged. | ||
Great Portland Estates (LON:GPE) (£1.37bn) | Two thirds of building already let or under offer significantly ahead of ERC. | ||
Volex (LON:VLX) (£664m) | Q1 in line, organic revenue +10.4%. Confident in ability to meet FY2026 expectations. | ||
Morgan Advanced Materials (LON:MGAM) (£630m) | 25H1 Revenue -9% to £522.6, adj. Op Profit - 19% to £58m, adj. EPS down 27% to 10.8p. Net debt excl. lease liabilities up 12% to £249.1m. | BLACK (AMBER/RED) (Mark) [no section below] | |
| Petrotal (LON:PTAL) (£364m) | Q2 2025 Financial and Operating Results | Average Q2 2025 sales & production of 20,578 & 21,039 (Q1: 23,286 & 23,281 respectively). Revision of 2025 production guidance to a range of 20-21kbopd down from 21-23kbopd, on capital spending of $80 million. | |
Mears (LON:MER) (£333m) | Revenue +4% to £559m, PBT +5% to £32m, average daily net cash flat at £66.7m, EPS +20% to 27.7p partly due to share count reduction. | AMBER/GREEN (Graham) Those who are more comfortable with this sector might argue that I should be fully GREEN on this stock now, but I'm conscious that earnings are forecast to decline in the years ahead (even after strong upgrades today at Panmure Liberum). Mears has very high exposure to asylum-related contracts whose long-term future is uncertain. As such, I do think that a cheap-ish earnings multiple might be fair. | |
Gore Street Energy Storage Fund (LON:GSF) (£314m) | “Both PIRC and ISS have issued clear guidance to shareholders to VOTE AGAINST all resolutions proposed by RM Funds.” | ||
Vanquis Banking (LON:VANQ) (£264m) | 25H1 PBT continuing ops of £6.2m (24H1: £46.1m loss), Return on Tangible Equity 3.1%, in line with guidance. Customer balances up 7%, improved credit quality. Financial guidance for 2025 and 2026 remains unchanged. | AMBER/GREEN (Graham) I can upgrade this now as we have a positive, stabilising trading update. The last time I looked at it, it issued a profit warning, and before that, it was suffering from a variety of problems. The balance sheet looks very safe and it trades at a big discount to NAV, so I’m happy to give it an upgrade. | |
CLS Holdings (LON:CLI) (£258m) | Lettings totalling 8,040 sq. ft (747 sqm) at The Coade, 98 Vauxhall Walk, London at an average of £48/sqft. | ||
accesso Technology (LON:ACSO) (£176m) | Confirms a key enterprise contract renewal as part of its long-standing partnership with Six Flags for accesso Passport® eCommerce ticketing platform across all 42 theme and water parks in North America. | ||
Epwin (LON:EPWN) (£124m) | 120p cash, 32% premium to last night’s close. |
PINK (GREEN) (Mark) | |
Sanderson Design (LON:SDG) (£36.1m) | HY25 sales down 4% to £48.3m, of which licensing +7% to £4.4m. Net cash £7.5m (FY24: £5.8m) due to planned inventory reduction. FY expectations unchanged. | AMBER/GREEN (Mark - I hold) | |
Empresaria (LON:EMR) (£22.7m) | 25H1: NFI flat at £23.4m, adj. PBT +350% to £0.9m, Net debt excl. leases £16.1m (FY24: £15.1m), no dividend. | PINK (AMBER/RED) (under offer) [no section below] | |
Robinson (LON:RBN) (£20.9m) | Parts of Walton Mill sold for £700k (+ contingent £315k if there is a resale within 18mo) vs £546k book value. Boythorpe works option agreement gives company £2.85m (vs £613k BV) if buyer receives planning permission within 24 months. | AMBER (Mark) [no section below] | |
Altitude (LON:ALT) (£14.4m) | FY Revenue +24% to $37.3m, adj. Operating Profit +21% to $3.7m, adj. EPS +11% to 2.24c. Cash $0.7m (FY24:$1.5m). | ||
KRM22 (LON:KRM) (£15m) | H125 revenue +12% to £3.7m, Adjusted EBITDA flat at £0.3m. Cash balance £1.4m (24HY: £1.0m). ARR +20% to £7.2m. | ||
Blackbird (LON:BIRD) (£14m) | “... a contract win with an OEM partner for use at a global Winter Games in 2026.” | GN: This is a Reach announcement, i.e. a non-regulatory press release. | |
React (LON:REAT) (£11m) | “The Group continues to make encouraging commercial progress, securing a high volume of small and medium-sized contracts in each of its divisions” No figures given. |
Graham's Section
Mears (LON:MER)
Up 3% to 397p (£343m) - Interim Results - Graham - AMBER/GREEN
Mears Group PLC, the leading provider of housing services to the public and regulated sectors in the UK, announces its interim financial results for the six months ended 30 June 2025 ("H1 2025").
A great headline here: Excellent first half performance; solid growth in Maintenance activities and strengthening operating margin.
Some key points:
Revenue -4% (£559m), “with some normalisation in the Group’s Management-led activities”.
PBT +5% (£32m).
Adjusted operating margin improves from 5.2% to 5.6%.
There are “new orders to a value approaching £1.5bn” in an “abnormally busy period for contract rebids”, and Mears has achieved 100% contract retention.
Major customers mentioned include Milton Keynes City Council, Moat Homes, London Borough of Brent and Aberdeenshire Council.
Current trading and outlook:
The business has continued to perform strongly. Increasing confidence in growth momentum of Maintenance-led activities
The precise timing of the normalisation of AASC revenues [GN note: asylum accommodation and support contract] remains uncertain, but there is a clear political drive to see all hotel accommodation exited during 2026, reflected in today's guidance.
The Board expects adjusted profit before tax for the full year to be modestly ahead of market expectations. This positive performance also gives the Board increasing confidence in its expectations for the next financial year
AASC revenues have been responsible for a large percentage of Mears’ total revenues in recent years, so it’s crucial to try to understand how long this might last for.
In a longer “outlook and guidance” section later in the report, the company provides the following:
ARAP is the “Afghan Relocation and Assistance Policy”.
So both AASC and ARAP are expected to see revenue reductions in the years ahead, with particularly large revenue reductions from AASC.
PBT guidance for FY 25 (left-hand column) and the “Medium term” (right-hand column).:
The margin guidance is for an operating margin of 5.3-5.6% (FY25) and 5-6% (Medium term).
Let’s do the calculation for FY25 - a company like Next (which I own) would do this for us, but not every company is like Next!
FY25 maintenance revenue: £600-606m.
FY25 management revenue: £677m.
FY25 total revenue: £1,277m - 1,283m.
Adj. operating margin 5.3-5.6%, so adj op profit should be c. £68-72m (FY24: £63.6m).
Other factors will reduce that to a lower PBT figure, and then apply 25% tax.
Still, it creates a modest earnings multiple:
Broker estimates
Panmure Liberum have put forward an EBIT estimate of £67.7m for the current year (EBIT is typically the same as operating profit). This is consistent with my calculation of c. £68-72m.
Their previous forecast was only £62.5m.
Future years also get upgraded, but they are still falling with lower AASC/ARAP revenues.
The new EBIT forecast for FY26 is £59.1m (previous forecast: £52.6m).
The new EBIT forecast for FY27 is £56.1m (previous forecast: £50.7m.
EPS is forecast to fall from 50p (FY25) to 41.2p (FY26) and then 38.5p (FY27).
Graham’s view
This is a Super Stock with a StockRank of 99, which is a good reason for me to stay positive on it. Last time, Roland was AMBER/GREEN.
I’m inclined to leave this at AMBER/GREEN, but it’s a close decision. Perhaps I should be fully GREEN?
Pros:
Cheap earnings multiple.
The positive earnings surprise today is material with upgrades of >10%.
100% contract retention proves a high level of customer satisfaction.
Net cash of £81m before leases.
Negatives:
High lease liabilities of nearly £300m (it’s the nature of the business, so a harsh criticism).
The declining forward profile of earnings suggests that it perhaps should trade on a cheap earnings multiple.
High exposure to particular contract types (AASC/ARAP) that might not be around long-term.
Most of the negatives are to do with the type of business this is, rather than anything Mears has done wrong. By its very nature, this is a lowish-margin services business tied to large contracts that may be lumpy at times.
On balance, I am more comfortable with AMBER/GREEN, but someone who is more comfortable with the sector might feel that fully GREEN is justified, especially considering the very strong StockRank.
Vanquis Banking (LON:VANQ)
Up 13% to 116.2p (£261m) - Interim Results - Graham - AMBER/GREEN
This is encouraging:
The turnaround of Vanquis remains firmly on track and is gaining momentum. The Group delivered two consecutive quarters of profitability in the first half and has grown gross customer interest-earning balances over the last three quarters.
I was neutral on this in March, which was overly negative, but the company had just released a profit warning with a big impact on 2025 numbers. It looks like I’ll be upgrading my stance today.
Motor finance: no regulatory impact here (but don’t hold me to this!) as Vanquis did not pay discretionary commissions, and their position “is clearly differentiated from the unfair relationships decision” in the test case. The last time we looked at this, they said something similar - this is really just confirmation of what we already knew.
Financial highlights:
H1 PBT from continuing operations of £6.2m, ROTE 3.1% (guidance: low single digit ROTE).
Customer balances grew 7% to £2.46bn, with VANQ set to exceed previous guidance of £2.6bn by the end of the year.
Complaints down 36% year-on-year, with a big reduction in Financial Ombudsman fees, and complaint costs to fall again in H2.
Income Statement: Net interest income hasn’t changed, but impairment charges and operating costs are both much lower, which gives rise to the small profit (vs. very large losses in previous periods).
Balance sheet: tangible net asset value inches higher to £362m. So the stock is trading at a 28% discount to this.
Tier 1 Ratio: a standard measurement of bank safety, this is slightly lower now at 18.5% but still very high by traditional standards. Perhaps even too high! There is a point at which banks aren’t taking enough risk. Although given the recent losses here, it’s understandable that investors would want the reassurance of a strong balance sheet.
Retail deposits provide 84.6% of VANQ’s financing and the average cost of funds is 5.3% - this is on a downward path as rates gradually fall.
Outlook: unchanged, except that customer balances are ahead of the previous target for 2025.
There is no dividend, which is fair enough given the circumstances. Management are focused on “deploying capital to support growth initiatives”. The dividend question will be addressed again when they’ve delivered their strategy next year.
Graham’s view
I tend to look positively on cheap lenders, although I haven't been able to get off “AMBER” on this due to the losses it was experiencing, and then the profit warning in March as it began to stage a recovery.
In hindsight I was too slow getting positive on it, but for what it’s worth I’m happy to be AMBER/GREEN on VANQ today.
Positives:
There is still a large discount to tangible NAV.
No motor finance regulatory issue (I think!)
Accounts are much, much cleaner than they were before:
There is no dividend yet but for investors who can look past that, I think it's a nice candidate for further research:
Mark's Section
Sanderson Design (LON:SDG)
Up 9% to 54p - Half Year Trading Update - Mark (I hold) - AMBER/GREEN
While sales here are in line, they are also down:
Group sales in the six-month period were in line with Board expectations at £48.3 million (H1 FY25: £50.5 million), down 4% in reported currency and down 3% in constant currency
Product sales are worse if you consider that licensing sales have grown:
Licensing revenue performed well at £4.4 million (H1 FY25: £4.1 million), with strong growth of 22% in underlying performance (licensing revenue excluding accelerated income under IFRS 15)
However, this is undoubtedly good news as licensing is relatively high margin. The picture is complicated as the accounting regulations require them to recognise the licensing revenue from minimum guaranteed sales upfront, whereas the cash will be received over the next few years as products are developed, launched and sold by licensees. The risk is that if the company pushes to make licensing sales for a period, this will show strong growth, but when the signing of new deals tails off the accounting regulations will mean they show declining revenue. That this figure is growing in a tough retail market is a good sign. Good underlying performance is nice to have, but should be expected from previously signed deals. H2 as stronger than H1 on the licensing side last year. They say FY licensing revenue is expected to be broadly similar (i.e. slightly below)
Looking at the details, all regions are struggling, apart from the US. I’m generally not a fan of US exposure, given the highly uncertain tariff and decision-making environment there. However, their designs appear to be gaining traction in this market, despite the headwinds:
The weakness in internal manufacturing is due to their focus on delivering sales from inventory in the period. So it is good news when they say:
Third-party manufacturing at £9.2 million was in line with the same period last year and, as mentioned earlier, our factories' future financial performance has been transformed by the restructuring initiatives implemented earlier this year. The decrease in internal manufacturing revenue at £5.3 million (H1 FY25: £8.0m) was in line with our planned inventory reduction strategy. We continue to expect manufacturing to achieve break-even, or slightly better, for the current financial year.
I have a theory that they have been slow to react to weakening market conditions and cut costs, and part of this was due to the strength of the licensing revenue. The initial downturn in trading last year seems to have caught them by surprise, and given how strong the licensing revenue was last year, and their net cash position, they could still report a profit on lower volumes, so didn’t want to make employees redundant unnecessarily. However, this lack of action in a market that continued to be weak has led to a brokers’ consensus that looks like this:
They appear to have grasped the nettle now, though. As well as getting manufacturing to break-even on reduced volumes, they are targeting central costs:
Continued focus on cost efficiencies - management is well-advanced with a new initiative to further reduce central overhead costs by approximately £1 million on an annualised basis.
Given the consensus for net profit this year is £3.7m, this would be material to the bottom line, at least when fully implemented. However, the impact is already accounted for this year as they say “The Board's expectations for the full year remain unchanged.” Unsurprisingly, given this statement, brokers’ forecasts are unchanged. The other aspect of this that is potentially positive is that one way to get manufacturing to break-even would be to re-allocate some of the costs centrally. They don’t appear to have done this.
One of the other risks of being tardy to implement cost-cutting measures was that their net cash was reducing, and combined with a new lease on their Chiswick headquarters, meant their financial position was weakening:
This appears to have reversed in 25H1, where they have seen an increase in net cash (excl. leases):
The Group's balance sheet has strengthened in the first half with net cash of approximately £7.5 million as at 31 July 2025 compared with £5.8 million at 31 January 2025 (H1 FY25: £9.6 million). The increase in cash reflects a planned reduction in inventory and net cash is expected to continue to build in the remainder of the financial year.
Paid-for research provider Progressive have £8.5m net cash pencilled in for the FY, rising to £11.8m in FY27. Based on their forecasts, Progressive calculate the business is trading on 2.8x EV/EBITDA, dropping to 2.6x for FY27. This looks too cheap, given that the company now appears to have taken the appropriate action to adapt their business to current market conditions.
Mark’s view
This is ultimately an inline update. However, it also allays some of the concerns I’ve had about this business: were they willing to cut their coat according to their cloth? Would further licensing deals be difficult in current market conditions? Would tariffs have a severe impact on their US business? As such, the current rating of 2.6x FY27 EV/EBITDA looks too low for a company that looks close to a cyclical low in trading. Backing up this view, I calculate that they still trade at a discount to TBV, and I am sure that their intangible assets have value, too, as they are generating decent licensing revenue. I am happy to retain my AMBER/GREEN view (and holding).
Epwin (LON:EPWN)
Up 30% to 118p - Recommended Cash Offer - Mark - PINK/GREEN
Good news for holders here as it is a takeover offer. The premium offered is the fairly standard 30%ish to last night’s close. Shareholders will get 120p in cash. It doesn’t look particularly generous compared to where the company’s shares have been trading at various points during this year:
However, it is above the level that the shares have traded at in the last 5 years, and I’d imagine that isn’t a coincidence.
Even adjusting these figures in my head for the 30% rise today, this does look like the company is being sold on the cheap:
However, we have to accept that the medium-term revenue growth here is fairly lacklustre:
And the long-term average returns on capital nothing to write home about:
It has been a fairly consistent cash generator, though, and I can see why an acquirer would want to own this:
The acquirer is Laumann Group, a German family-owned business with €1.6bn of sales and €0.8bn of net assets. They are a market leader in PVC window profiles through their brands VEKA and GEALAN, also offering aluminum frames and facade systems, including PVC-based solutions like VEKAPLAN and Vinylit. So they seem a good fit as an industry acquirer:
In the view of the Laumann Board, the Acquisition aligns closely with Laumann's strategic priorities and will help to accelerate the implementation of Laumann's growth plans within the UK, as well as unlocking additional opportunities for operational synergies through sharing know how and technical infrastructure, scale benefits, and complementary offerings across key end-markets.
The offer is recommended by the Epwin board, although they only hold 0.6% of the equity. Laumman has irrevocable undertakings from Kennedy Capital Investments Limited, the trustees of The Anthony James Rawson Business Will Trust and Pentwin Group Limited in respect of a total of 40,500,000 Epwin Shares, representing, in aggregate, approximately 29.8 per cent. They also have a LOI from Otus Capital Management giving around 35% of the shares intending to vote for the offer scheme in total. They may get more now the offer is public. However, I don’t think these would stop a counter-offer if it was forthcoming.
Given the industry, I’m not sure any counter-offer would be that generous. Epwin’s board say:
…the valuation multiple implied by the Acquisition of 6.1 times Epwin's 2024 post-IFRS 16 Adjusted EBITDA is consistent with recent transaction multiples in Epwin's segment of the building materials sector;
However, it does highlight two things, Firstly that wider industry players may be seeing the possibility of a recovery in UK building products on the horizon. Secondly that very similar company, Eurocell is on almost the same rating as Epwin prior to this offer, which may highlight the value there as well:
Mark’s view
Roland rated this as GREEN following their AGM statement in May and he has been proven right to do so as an industry player has also seen the attraction. While I think the chance of a counter offer is slim, and if I held, I’d be tempted to recycle the proceeds into other UK building products suppliers, I see no reason to change the rating at this stage.
Disclaimer
This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.


52 comments
Hello Graham,
Amber/green is probably fair for Mears (LON:MER) . I do think forecast EPS can be beaten, management seem quietly confident regarding FY 26.
Maybe I'm biased but I reckon a viable takeover target too. The proof will be in the pudding!
I would be wary about the positive US sales trend reported by Sanderson Design (LON:SDG) in the first half. Mark you mention headwinds in the US (related to tariffs) but if Colefax is accurate in its commentary it is reporting exceptional tailwinds in the US which it does not expect to be sustained.
Colefax (LON:CFX) on 29 July (in its full year results, year ending April) said it had seen "a very strong surge in US sales during the final quarter of the year [this means February to April 2025] . We believe this is mainly exceptional and related to orders accelerated to avoid tariff increases. This has continued in the first two months of the current year [i.e May and June] during the pause in tariffs announced by the US government but we do not believe it is likely to be sustained."
So the period (Feb- June) that Colefax is reporting exceptional and unsustainable demand in the US almost exactly matches Sanderson's first half (February to July).
One caveat that I would say is that Colefax (I hold) is usually quite cautious in its commentary.
Good point Wimbledonsprinter, and something I probably should have thought about, given that I also hold a bit of colefax. I don’t think Colefax have their own manufacturing which may mean that the effect is less severe for Sanderson who presumably have the UK’s 10% tariff only to contend with. Sanderson are also reporting for an extra month, so it seems if this is a short-term effect it is at least continue the moment. hHowever, it is certainly something to keep an eye on going forward for both businesses.
I think Coleman in importing from China. Sanderson from the UK. The tariff situations are very different.
Can't keep up with these tariffs, is China 30% and UK 18%, still?
Prices from China will be much lower than if produced in UK?
Positive. I've been caught too many times on averaging down on falling stars, SDG has never been a high growth share but we are still nursing losses and will add a few more to a growing number held. Thank you Mark for the comprehensive review.
B.P. Marsh & Partners (LON:BPM) - a favourite here - Any comments on the placing of entire holding of major shareholder PSC today?
looks like B.P. Marsh & Partners (LON:BPM) been trading in a range since Feb from about 620-705
CRH (LON:CRH) - Graham - missed from the table and (also myself ) till I noted they a top riser today up 8%. Results good - maybe missed because their main listing is now NY. Something else to watch out for....
we added it, thanks bohenie!
I couldn’t agree more! It’s awful! Clearly someone had too much time on their hands!
BBC News - https://www.bbc.co.uk/news/live/cedvn267z0jt
Bank of England expected to cut interest rates - live updates - BBC News
I'm hoping the team will cover Vanquis Banking (LON:VANQ) results today. Seem to be reassuring making this an attractive turnaround and with a significant discount to book value.
Mello London in November has launched and early bird tickets are available...
MelloLondon returns to Chiswick on 18th & 19th November | By carmensfella | Stockopedia
No PTAL coverage on their Q2 figures?
Can someone remind what a black rating means please. Thx.
Black means profit warning
It would be helpful to have a key to the colour coding as part of the header to the DSMR.
MGAM Revenues drop 9%, causing the share price to drop 16% in early trading.
I had heard of a fund manager take a position earlier this year, singing its praises. It's on a fairly cheap valuation (PE 8.5, yld 5.5%). I had a look at it for its a potential as a LTBH. I rejected it though, because its revenues and EPS hadn't really gone anywhere over the last decade.
Sure enough, 10-year performance in share price has been disappointing, trading at 355p then compared to 188p now.
Might be one for income investors as the dividend is well-covered. Interest cover of 5.6 is acceptable, although I'd prefer more. Not to my tastes, though.
Think you might have slipped the wrong notes on beside CLS Holdings
fixed it, thanks for letting me know! G
Volex (LON:VLX) Business progressing as expected. "Q1 FY2026 constant currency organic revenue increased by 10.4% year-on-year."
Does anyone else think the new drop down for time period on the share price graph on the stock report is a bad idea?
This means that it now takes two clicks to change the scale, not one. The no of options has also reduced so we can only see up to three years.
Also, there is no benefit for the display as there is just white space where the options used to be.
David
I agree, the old approach was better.
Completely agree. Change for the sake of change. Why bother? Just leave things as they were. It was working well. Please change it back immediately, Stocko.
I’m keen that Stocko keep trying new things, the site has improved loads in the last few years, the dev team should be proud of themselves, stocko is great.
That said I preferred the older date selector, but you can’t make an omelette without breaking a few eggs so not every new development will hit the mark.
Agree. Terrible idea - I flit between time periods so this is a mistake. Please change it back.
Also if you use a phone to read the report the table is a pain you need to scroll back and forth, back and forth- where it used to fit the ‘page’ which was much easier to use, even with more columns than now
Mine doesn't even work properly. If I select 1 month it shows 3 months, if I select 3 months it shows Ytd and so on.
Whichever one you choose, you get the next one down. Choose the bottom one to get the top.
Yes, l reported this yesterday to Stockopedia. They are looking into it.
Hello David - I apologise, this was an unintentional change. We will be reverting the date picker back to its previous version soon.
Interims from Vanquis Banking (LON:VANQ) look solid. The recovery looks to be well on track and the next couple of years could be very positive for the company and for shareholders. Happy to hold and continue to watch as the recovery unfolds.
Not a bad morning for us, a recommended bid for Epwin ,which imo looks low at 120p, and a sound update from Sanderson Design. Cash seems healthier as stocks have been reduced while licensing revenue continues to grow. They are excited about a coming launch of a never before produced William and Morris design, this might interest any subscribers living in a castle, or those who just like wallpaper. We are long term holders of both companies and have added a few times to Sanderson. I'd appreciate coverage if there's time and I always enjoy subscribers comments.
Epwin (LON:EPWN) has been on my watch list for some time, but never quite made it to the top of the BUY pile. Certainly didn’t see this bid coming and judging from recent share price performance, neither did the rest of the market.
Epwin (LON:EPWN)
Agree this is extremely low ball offer - I guess the only good news here is that at present is that for me simply recycling proceeds into Eurocell is a simple carry on as you were option - if the Eurocell price doesn’t jump in the meantime.
Eurocell is only on or of 7 so it’s got similarly cheap rating and whilst not being identical in nature to Epwin they are uber similar.
I was happy with Epwin board and they seemed to do well in their niche - so perhaps Epwin might have had more niche market than Eurocell - so not sure if euorocell have slightly more general offerings ? Perhaps a sector that might have little structural growth with plenty of companies selling maintenance and building products.
Hey ho looks like the board will be very well looked after by new owners so they are putting up no fight - so with board being patsies that only leaves hostile bid. I doubt anyone else is going to offer more than 10p over current offer - clearly this sector isn’t highly rated so any offer at the current level is at least clearly a premium to where we have been and on that basis it’s probably time to move on.
Perhaps brickability might be alternative home fir recycling cash - not 100% convinced though about long term prospects of cladding companies they have acquired (huge backlog of work now but what happens when backlog tails off?) - I think directors have sold there too.
Weird isn't it, in theory it's the quiet season and yet so far in the last two weeks I've had bids for JUST, IPF and now EPWN. There won't be much left in London at this rate!
Better start researching US markets as all the good UK companies will have disappeared before too long.
Yes that was what l was thinking, so many take-overs and stocks moving to other markets, hardly any new companies floating, there won't be anything decent left.
This my third bid in under 3 weeks, other 2 were Alpha International (LON:ALPH) and Just (LON:JUST).
Agree entirely. My portfolio has done fantastic this year but it is all short term success - most of the companies that are going, I thought were long term buy and holds, companies I rate and thought I'd hold for many years, potentially decades, instead I've made a pleasant and well received fast buck and obviously it is nice to see my portfolio doing well but I am finding myself thinking more and more whether it makes sense to stay in the UK stocks game.
I might just change to some strategy where I put 80% of my portfolio in some ETF and hold just a few targeted positions other than that, for the little bit of cream that is left to us UK investors...
While not unhappy to net 20% gain following the recent downward movement, had the potential offer been disclosed at any point between March and today things would no doubt have been very different with a price nearer 150p either from this bidder or from a counter offer.
I sold at 118.4p and will recycle it to top up at HSS Hire (LON:HSS) and a speculative opener at Ondine Biomedical (LON:OBI)
Hi Bouden54
'Better start researching US markets as all the good UK companies will have disappeared before too long.'
I agree, so I've shifted to US equities, which have significantly outperformed my past UK investments. Adapting to the US market, I found, required a mindset shift:
Regards
Howard
Hi Howard
Would be interested to know which sources you use to research the US market - do they have equivalents to the likes of Stockopedia, Investor Meet Company or Research Tree. What I find really useful are places where you can find knowledgeable reader commentary. I'm sure there's a lot out there but don't quite know where to start.
Hi Bouden54
Thanks for your response.
'Would be interested to know which sources you use to research the US market'
I research the US market by watching the last hour of Bloomberg Surveillance (1-2pm UK time) for broad financial insights. I use YouTube for CNBC, Yahoo, Bloomberg Tech, Schwab, and others, searching company-specific content and following specialist podcasters.
I track portfolios on Stocko, follow US market posts on X, and monitor watchlists on Google Finance for real-time prices and pre-market moves.
I invest via Hargreaves and am experimenting with Robinhood for cheaper trading and fractional shares, real time prices, FX only occurs when you transfer/extract dollar shares in/out to sterling. And much more (still early days on this).
For equivalents to Stockopedia, Investor Meet Company, or Research Tree, there are similar services, but my current sources meet my needs.
My suggestion to step into the US. Focus on a sector. After researching your area of interest, your feeds from Bloomberg, X, and YouTube will begin to push relevant content to you. Then the more you do the better your feeds become. It takes a while but worth it.
Let me know if you want specifics.
Regards
Howard
That's great, thanks for that. I think focusing on a couple of sectors is a good approach, and what I tend to do in the UK as well.
Hi Bouden54
This X post is a reason I focus on the US market.
Regards
Howard
I am focussing on the semi- conductor and nuclear energy/uranium sectors via Van Eck ETFs
Long time ago figured that out. I use Seeking Alpha.
The contributors really go deep into the company, what it does, its competitors and the comments are focused on that company and very interesting in themselves.
I don't focus on accountancy, hence leave that to stocko algos and similar with Seeking Alpha. And love Rolands education on that - see a red button can look into it why and not just ignore.
Not small cap territory but not looked them to be honest - but there small cap is probably $1bn lol. Who's going to write up about a $10m MC waiting to be gobbled up - only insiders know that game.
SA has a good rating system and gives a confirmation to Stockos so two confirmations of your own bias :)
I like Stockos clean charts and good visuals for the macro - but when for quick analysis of what's moving or 15min level then TradingView or your own brokers. If don't have one like AJBell then more pension coffers can than trader hence good for ETFs etc.
Someone on here worrying about FX in their buying/selling. Just open an account with IBKR pump in the cash, convert to dollars when the rate is good and away you go dollar to dollar. Want to draw some out then do the same when the FX trade is in favour.
Have fun. Make life simple - too much problem dealing with people or opening up Twitter/X.
Any good podcasters out there appreciate a heads up. The 'media' is predictably poor so some of the disruptors. This is the future imo - maybe see Rachel Reeves pod soon explaining how she's going to rob your pension.
Very poor offer for EPWIN - it was actually trading at 109p as recently as June. If we ever see a decent recovery in construction this would have easily got to 150p
The price is very close to the offer, could have got 119p this morning, it has dropped back slightly now.
Sanderson Design (LON:SDG) Long article in the FT's glossy HTSI magazine this week on the new William and Morris designs
Morning All,
Mears (LON:MER) good interims, revenue down due to management led activities normalising, as guided.
Maintenance doing well, operating margin is up, earnings and divi both increased at 20 and 18%.
I hold